HDAC9 and lymphoma: Considerable evidence suggested some connection between HDAC inhibitors and ER stress in other disease models including lymphoma (Cosenza et al., 2017), breast cancer (Komatsu et al., 2013) and Duchenne muscular dystrophy (Consalvi et al., 2014).